Attempted preservation of one gonad in patients with bilateral germ cell tumours

Clinical Oncology

Volumn 8, Issue 6, 1996, Pages 397-399

  Gomes, P J ^a   Rustin, G J S ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Dysgerminoma; Fertility; Germ cell tumour; Testicular neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; SEX HORMONE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DYSGERMINOMA; ECHOGRAPHY; FEMALE; FERTILITY; GERM CELL TUMOR; HORMONE SYNTHESIS; HUMAN; MALE; ORCHIECTOMY; PRIORITY JOURNAL; SEMINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DYSGERMINOMA; FEMALE; FERTILITY; HUMANS; MALE; OVARIAN NEOPLASMS; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0030431045     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(96)80090-2     Document Type: Article

References (15)

1. Foster RS, Donohue JP. Surgical treatment of clinical Stage A nonseminomatous testis cancer. Semin Oncol 1992;19:166-70.
2. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for Stage I testicular teratoma. J Clin Oncol 1992;10:1762-8.
3. Peckham MJ, Barrett A, Liew KH, et al. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer 1983;47:613-9.
4. Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer 1986;53:501-5.
5. Boyle P, Kaye SB, Robertson AG. Changes in testicular cancer in Scotland. Br J Cancer 1986;23:827-30.
6. Pektasides D, Rustin GJS, Newlands ES. Fertility after chemotherapy for ovarian germ cell tumours. Br J Obstet Gynaecol 1987;94:477-9.
7. Pelletier RM, Byers SW. The blood-testis barrier and Sertoli cell junctions: Structural considerations. Microsc Res Tech 1992;20:3-33.
8. James PPB, Mead GM. Sanctuary site relapse in chemotherapy-treated testicular cancer. Ann Oncol 1992;3:41-3.
9. Simmonds PD, Mead GM, Lee AHS, et al. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Cancer 1995;75:1018-24.
10. Van der Maase H, Rorth M, Jorgensen SW, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: Study of 27 cases in 500 patients. Br Med J 1986;293:1398-401.
11. Thompson J, Williams CJ, Whitehouse JMA, et al. Bilateral testicular germ cell tumours: An increasing incidence and prevention by chemotherapy. Br J Urol 1988;62:374-6.
12. Fossa SD, Aass N. Cisplatin-based chemotherapy does not eliminate the risk of second testicular cancer. Br J Urol 1989;63:531-4.
13. Weissbach L. Organ preserving surgery of malignant germ cell tumours. J Urol 1995;153:90-3.
14. Heidenreich A, Bonfig R, Derschum W, et al. A conservative approach to bilateral testicular germ cell tumours. J Urol 1995;153:10-3.
15. Giwereman A, Rajpert-De Meyts, Skakkebaek NE. Carcinoma in situ of the testis: A new biological concept of urologic relevance and implications for detection and management. In: Comprehensive textbook of genitourinary oncology, eds Vogelzang NJ, Scardino PT, Shipley WV, Coffey DS. Baltimore, Williams & Wilkins 1996;52:941-52.